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Relationship of Omega-3 Fatty Acids on C-Reactive Protein and
Homocysteine in Haitian and African Americans with and without Type 2
Diabetes
Fatma G. Huffman*, Joan A. Vaccaro, Joel C. Exebio, Sahar Ajabshir, Gustavo G. Zarini and Lemia H. Shaban
Department of Dietetics and Nutrition, Florida International University, USA

Abstract
Background: Omega-3 fatty acids (n-3) may be protective of cardiovascular risk factors for vulnerable
populations. The purpose of this study was to assess the association between n-3 with, C-reactive protein (CRP),
and homocysteine (HCY) in Black minorities with and without type 2 diabetes.
Methods: A cross-sectional study was conducted with 406 participants: Haitian Americans (HA): n=238. African
Americans (AA): n=172. Participants were recruited from a randomly generated mailing lists, local diabetes educators,
community health practitioners and advertisements from 2008-2010. Sociodemographics and anthropometrics were
collected and used to adjust analyses. All dietary variables were collected using the semi-quantitative food frequency
questionnaire (FFQ) and used to quantify vitamin components. Blood was collected to measure CVD risk factors
(blood lipids, HCY, and CRP).
Results: African Americans had higher waist circumferences and C-reactive protein and consumed more
calories as compared to Haitian Americans. Omega 3 fatty acid intake per calorie did not differ between these
ethnicities, yet African Americans with low n-3 intake were three times more likely to have high C-reactive protein as
compared to their counterparts [OR=3. 32 (1. 11, 9. 26) p=0.031].
Although homocysteine did not differ by ethnicity, African Americans with low omega 3 intake (<1 g/day) were four
times as likely to have high homocysteine (>12 mg/L) as compared to their counterparts, adjusting for confounders
[OR=4.63 (1.59, 12.0) p=0.004]. Consumption of n-3 by diabetes status was not associated with C-reactive protein
or homocysteine levels.
Conclusions: Consumption of n-3 may be protective of cardiovascular risk factors such as C-reactive protein
and homocysteine for certain ethnicities. Prospective studies are needed to confirm these results.

Keywords: n-3 fatty acids; Homocysteine; C-reactive protein;
African Americans; Haitian Americans; Type 2 diabetes
Introduction
Cardiovascular disease (CVD) is one of the most prevalent causes
of morbidity and mortality worldwide [1]. Since it is possible to have
normal blood lipids and be at risk for CVD, other blood markers such
as C-reactive protein (CRP) [2-3] and homocysteine (HCY) [4] have
been considered independent risk factors for CVD. It has been wellestablished that CVD involves systematic inflammation [5]. Prospective
studies and primary prevention trials have demonstrated that CRP, an
acute phase protein and marker of chronic, low-level inflammation,
predicts CVD risk as well as CVD in those without prior disease [6].
High blood levels of HCY are thought to play a role in endothelial
damage through oxidative stress-based on molecular studies and
have been established as a risk factor for CVD by retrospective and
prospective studies [4].
Omega-3 fatty acids (n-3) have been associated with antioxidant
properties related to the reduction of CVD risk in observational and
randomized control trials [7]. In addition to their antioxidant properties,
n-3 may be associated with reducing systemic inflammation. N-3, a type
of polyunsaturated fat derived from either fish (as eicosapentaenoic
acid (EPA) or docosahexaenoic acid (DHA) or plant sources,
α-linolenic acid (ALA) have been shown to have a protective effect
on cardiovascular disease (CVD) risk in numerous epidemiological
studies [8-11]. Whether this effect is due to their antioxidant or antiinflammatory capacity, it has not been clearly established.
J Nutr Food Sci
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Participants with diabetes are under increased oxidative stress due
to factors such as: auto-oxidation of glucose which produces more
free radical formation, imbalances in cellular oxidation and reduction,
and decreased antioxidant defense systems [12]. Atherosclerosis and
atherothrombosis processes are up-regulated in persons with diabetes
[13]. Individuals with diabetes have more than double the risk for CVD
as compared to their counterparts [14]. 90-95% of the cases of diabetes
type 2 incidences (T2D), has been attributed to genetic predisposition
and lifestyle factors such as diet, physical activity, alcohol, obesity, and
smoking [14].
Blacks are among those at high risk for and a higher prevalence of
diabetes (11.8%) which places them at greater risk for CVD [14]. There
is limited research on T2D and CVD risk factors in Haitian Americans
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(HA) and African Americans (AA). The majority of the existing data
groups Blacks together; hence, there are no clear distinctions and
acknowledgement of the widespread differences in culture, foods, and
lifestyle among Black subgroups. In addition, there is no research, to
date, on the association between n-3 with CVD risk factors specific to
Black populations with T2D. It is possible that ethnicity may modify
the effect of n-3 on either or both HCY and CRP. Therefore, this study
investigated the association of n-3 with biomarkers of CVD risk:
HCY and CRP, in HA and AA with and without T2D. The following
hypotheses were tested: Participants with low n-3 intake, regardless of
ethnicity and diabetes status, will be more likely to have: 1) high CRP,
and 2) high HCY. The establishment of cut-off points for n-3, CRP, and
HCY were based on clinical significance and the sample medians, as
explained in the Statistical analysis section.

Methods
Study participants
This was a cross-sectional study of AA and HA with and without
T2D. AA was recruited from Miami-Dade and Broward counties
in Florida, USA using mailing lists purchased from Knowledge Base
Marketing, Inc. The subjects were randomly selected by alternating
between subjects with and then without T2D. For AA, 7,550 letters were
mailed to potential participants with and without T2D, four percent
responded (n=256), and 6.3% (n=477) were returned due to unknown
addresses. HA participants (n=259) were recruited differently because
mailing lists were not available for this group. Recruitment was done
in the community through local diabetes educators and community
health practitioners in Miami-Dade and Broward Counties, who
were either former students or in close contact with the Department
of Dietetics and Nutrition at Florida International University (FIU).
Also, FIU faculty, staff and students, as well as, several residential
rental facilities received invitational flyers and were requested to assist
with the recruitment process. Advertisements were circulated in local
Haitian newspapers, churches, supermarkets, restaurants, and also
aired on local Creole stations. Interested participants were interviewed
on the phone to obtain age, gender, and T2D status. Exclusion criteria
consisted of those being younger than 35 years old, other ethnicity,
severe diabetes complication (blindness, amputations, kidney failure)
and having other major chronic diseases or illnesses, specifically, liver
disease, congestive heart failure, bariatric surgery, cancer, AIDS/HIV.
Eligible subjects were requested to come to the Human Nutrition
Laboratory at FIU for blood collection after an eight-hour overnight
fast; participants were asked to refrain from smoking and engaging
in any unusual exercise prior to this visit. The study was approved by
the Institutional Review Board at FIU. Written consent in English or
Creole was required from all participants; and, all participants signed
an informed consent form prior to enrollment in the study.

Data collection
Participants completed a socio-demographic questionnaire, which
included: age, gender, duration of residence in the USA, language
preference, education, income, employment status, medications, and
family history of T2D and CHD. Weight, height, waist circumference
and blood pressure were performed in the Human Nutrition Laboratory
of the Principal Investigator. Body mass index (es) (BMI) was calculated
as weight in kg/height in m2.
Blood sampling: A certified phlebotomists collected a 20 ml sample
of venous blood from each subject after an 8-hour overnight fast. A
vacationer Serum Separator Tube (SST) was used for the lipid profile
J Nutr Food Sci
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sample. After complete coagulation (i.e., 30-45 minutes), the SST was
centrifuged at 2500 rpm for 30 minutes. One sample of the serum was
used for lipid profile analysis and the other was frozen at -70°C for HCY
and high-sensitivity C-reactive protein (hs-CRP) analysis. Laboratory
results showed that 13 participants (HA=8; AA=4) who reported
not having diabetes were reclassified as having T2D according to the
American Diabetes Association Standards. These participants were
referred to their physicians and were included in the group with T2D.
Biochemical analysis: Plasma total cholesterol (TC), triglycerides
(TG), low-density lipoprotein cholesterol (LDL-C), and high-density
lipoprotein cholesterol (HDL-C) were assayed by enzymatic methods
(Cobas Mira, Roche Diagnostics, Indianapolis, IN). LDL-C was
estimated by the Friedewald formula: {LDL-Cl=TC (mmol/L)-HDL-C
(mmol/L)-TG (mmol/L) 2.2 (mmol/L)}. Hs-CRP was analyzed by
Immulite (Diagnostic Products Corporation, Los Angeles, CA). The
combined free and protein-bound plasma HCY was measured using
the IMx System based on the Fluorescence Polarization Immunoassay
technology (Axis-Sheild ASA, Oslo, Norway; Abbot Diagnostic
Division, Abbott Laboratories, Abbott Park, IL).
Nutritional variables: All dietary variables were collected using
the semi-quantitative food frequency questionnaire (FFQ) developed
by Walter C. Willett. This FFQ has been extensively validated and
standardized in several multiethnic population-based prospective and
cross-sectional studies and for determination of chronic diseases such
as CVD and T2D [15,16]. Participants reported their consumption of
various foods over the past year. This FFQ describes individuals’ intake
of macro- and micronutrients, dietary patterns, food habits, changes of
consumption in last 10 years, frequency of foods, usual serving size, and
servings per week of food items that are not listed. The FFQ has several
advantages: it is self-administered, inexpensive, subject burden is
minimal, and does not require specialized training for the participant.
Statistical analysis: Prior to analysis, all continuous variables were
tested by Q-Q plots and when needed were log-transformed to achieve
linearity. Total n-3 intake (from ALA, DHA, and EPA in food and
supplements) was transformed into a binary variable for adequate versus
inadequate intake in grams/day. Since no definitive recommendations
are given for n-3 cut-offs were considered as adequate for either 1 g or
2 g per day based on model fit. Participants were excluded if they met
one or more of the following conditions: 1) missing values n-3, HCY, or
hs-CRP; 2) CRP higher than 10 mg/L (n=95) since this elevation might
be a result of an acute infection and cannot be used to asses CVD risk
[17]; and 3) total energy intake <500 or >5000 kcal/day. A total of 490
participants (HA=238; AA=172) with and without type 2 diabetes were
included in the final data analysis. Logistic regression models were used
to assess the odds ratios for n-3 intake. One and two-way interactions
were tested for ethnicity and diabetes status with n-3. Analysis was
conducted for each ethnicity, based on the significance of the twoway interactions. Adjustment variables for final models included: age,
gender, smoking status, waist circumference, and Kcal/day. Covariates
vitamin B, saturated fat, fiber, and physical activity were tested along
with the adjustment variables and not retained. A binary variables were
created for HCY, where the 75th percentile and above was considered
high (12 mg/L) and for CRP, where high CRP was considered ≥ 3 mg/
dL. Data were analyzed using the statistical software IBM SPSS Statistics
version 19 (SPSS Inc, Chicago, IL) and statistical significance was set at
p<0. 05.

Results
General characteristics of the study population by ethnicity are
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African
American

Variable

Haitian
American

P-value

Categorical variables N (% within ethnicity)

significant for Haitian Americans (data not shown). Diabetes status and
diabetes by n-3 intake were not associated with HCY in this model. A
comparison of means was conducted for each ethnicity for HCY levels
and there were no differences by diabetes status for AA (p=0.235) and
for HA (p=0.412) (data not shown).

Gender (males)

93 (54.1)

115 (49.1)

0.327

Low n-3<1 g/day

43 (25.0)

97 (41.5)

0.001

High HCY
(>12 mg/L)

45 (26.2)

54 (23.1)

0.474

Discussion

High CRP (≥ 3 mg/L)

76 (44.2)

64 (27.4)

0.001

Current smoker

62 (36.0)

15 (6.4)

<0.001

This study investigated n-3 and its association with lipid profiles,
CRP and HCY in AA, and HA with and without T2D. Ethnicity modified
the relationship between omega 3 intake and the cardiovascular risk
markers, CRP and HCY. Most studies for n-3 intake with either CRP or
HCY are performed in specific populations, but do not compare across
ethnicities and diabetes status. Moreover, the association among n-3
and CRP levels in cross sectional studies and the effects of omega-3
supplementation/fish intake on serum CRP levels have inconsistent
findings. Similarly, n-3 interventions have produced inconclusive
results for HCY due to small sample sizes and short duration of
supplementation.

Continuous variables (mean ± SD)
Age (years)

53.3 ± 9.5

56.0 ± 11

0.008

Waist circumference (cm)

106.7 ± 17

97.9 ± 12

<0.001

Homocysteine (mg/L)

10.3 ± 4.0

10.2 ± 3.8

0.714

CRP (mg/L)

3.15 ± 2.5

2.21 ± 2.0

<0.001

N-3 (grams)

1.89 ± 1.3

1.49 ± 1.1

0.001

ln Kcal

7.57 ± .51

7.34 ± .51

<0.001

2199 ± 1043

1759 ± 942

<0.001

Kcal

Abbreviations: HCY=homocysteine; CRP=high-sensitivity C=reactive protein;
n-3=omega-3 fatty acids.
Table 1: General characteristic by ethnicity.
Variable

95% C.I. for OR p value
OR

Lower

African American

0.57

0.22

Upper
1.49

Haitian American (reference)

1.00

1.00

1.00

-

African American by low omega-3 fatty
acids

3.21

1.11

9.26

0.031

low omega-3 fatty acids<2 g/day

1.38

0.541

3.51

0.502

With type 2 diabetes

2.72

1.08

6.82

0.033

With diabetes by low omega 3

0.44

0.155

1.28

0.132

0.249

Model Summary: χ (10)=67.1 N=406 p<0.001
Nagelkerke R2=0.210.
The model classified 74% of the cases of CRP, correctly.
Model adjusted by kcal (p=0.307), waist circumference (p<0.001), gender
(p=0.262), smoking (p=0.587), and age (p=0.510).
2

Table 2: Odds ratio of high C-reactive protein (CRP) (≥ 3 mg/L) by omega-3 fatty
acid intake, ethnicity and diabetes status.

presented in table 1. There was no difference in the gender distribution
between AA and HA (p=0.327); albeit, AA were approximately 3 years
younger than HA. African Americans consumed more calories and
higher grams of n-3; however, n-3 per kilocalorie was not statistically
different between them (AA=0.859×10-4; HA=0.847×10-4). African
Americans had higher waist circumferences (p<0.001) and CRP
(p<0.001) as compared to HA; but there was no statistical difference
between ethnicities in HCY levels (p=0.714).
Table 2 depicts the logistic regression model for the odds of having
high CRP (≥ 3 mg/L) by n-3 consumption, ethnicity and diabetes status.
Low n-3 intake (<2 g/day) was not an independent predictor of CRP as
hypothesized. Instead, ethnicity by n-3 intake was significant. African
Americans with low n-3 intake were more likely to have high CRP as
compared to their counterparts [OR=3.21 (1.11, 9.26) p=0.032]. This
relationship was not significant for HA (data not shown). Although
having diabetes was associated with high CRP, as expected, diabetes
status by n-3 intake was not a significant predictor of high CRP
(p=0.132).
The logistic regression model for the odds of high HCY (>12
mg/L) by n-3 intake, ethnicity and diabetes status is presented in table
3. African Americans with low n-3 intake (<1 g/d) were more than
four times likely to have high HCY as compared to their counterparts
[OR=4.36 (1.59, 12.0) p=0.004]. Again, this relationship was not
J Nutr Food Sci
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Effect of omega 3 on CRP
Contradictory findings have been found for Caucasian populations.
Several intervention studies have shown improvements in CRP
corresponding to n-3 consumption among Caucasian populations [1820]. On the other hand, no improvements in CRP were found after a
placebo-control intervention with n-3 in a small sample of healthy,
middle-aged, Caucasian adults [21]. Conversely, an inverse relationship
between n-3 intake and CRP level was found for a large sample of
Caucasian men, aged 42-60 years [22]. A cross-sectional study of
healthy Australian adults showed an inverse association of CRP with n-3
intake [23]. N-3 levels assessed in blood were inversely associated with
CRP in a group of healthy adults [24]. Tumor necrosis factor (TNF-α),
another indicator of inflammation, but not CRP, was lowered after n-3
supplementation (2.4 g/day) for a small group of hemodialysis patients
[25]. C-reactive protein levels reduced after a 12-week intervention
for the group given n-3 and statins as compared to the control given
statins only in patients with dyslipidemia [26,27]. N-3 consumption in
the form of non-fried fish was associated with lower CRP levels in a
cross-section study of the multi-ethnic study of atherosclerosis (MESA)
cohort [28].
The metabolic role of n-3 as a supplement for individuals with
type 2 diabetes has a matter of debate due to a potential for increase
in hemoglobin A1c, fasting blood glucose, and lipid peroxidation
[28,29]. Shidfar et al. [29] found no effects on glycemic control or
lipoproteins with a supplementation of 2 g per day of n-3 and attribute

Variable
AA by low omega-3 fatty acids
(≤ 1 g/day)

OR

95% C.I. for OR
Lower

Upper p value

4.36

1.59

12.0

0.004
0.155

African American

0.61

0.31

1.20

Haitian American (reference)

1.00

-

-

-

Diabetes by low omega-3 fatty acids

1.02

0.36

2.90

0.965

Diabetes

1.10

0.59

2.03

0.770

Low omega-3 fatty acids (≤ 1g/day)

0.75

0.58

2.02

0.576

Model Summary: χ2 (10) (N=406)=30.9; p=0.001.
Nagelkerke R2=0.109. The model classified 75% of the cases of HCY, correctly.
The model was adjusted by age (p=0.001), gender (p=0.305), waist circumference
(p=0.225), smoking (p=0.029), and calories (p=0.765).
Table 3: Odds ratio of high homocysteine (HCY) (>12 mg/L) by omega-3 fatty acid
intake, ethnicity and diabetes status.
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disparate findings to differences in diabetes medications, the presence
of insulin resistance, hypertension, and obesity. Evidence for the
reduction of CRP by n-3 in populations with type 2 diabetes has not
been established. Several intervention studies showed no effect of n-3
supplementation on CRP for populations with type 2 diabetes [28,30].
C-reactive protein levels were not affected by n-3 supplementation (3
g/day for eight weeks) in a randomized control trial for persons with
type 2 diabetes; yet IL-2 and TNF-α, other indicators of inflammation,
were reduced in the n-3 group [30]. No significant changes in CRP were
found after two-month supplementation with n-3 for individuals with
type 2 diabetes; however, HCY levels were significantly reduced [28]. A
meta-analysis of n-3 and its effect on inflammatory factors from earlier
studies found only two trials evaluating CRP on individuals with type 2
diabetes [31]. N-3 did not significantly lower CRP for either trial [31].
However, n-3 in blood was inversely associated with CRP in obese and
non-obese, otherwise healthy, Greek adults [32]. These studies suggest
that low-grade, systemic inflammation, measured by CRP, is a chronic
disease indicative of life-long diet and may not be responsive to shortterm intervention.

Effect of n-3 with HCY
Supplementation with n-3 was associated with a decrease in
HCY according to a meta-analysis of 11 intervention trials [33]. N-3
supplementation was associated with the reduction of HCY for healthy
individuals [18], women [34], and for adults with type 2 diabetes and
dyslipidemia [35]. Several n-3 supplementation trial aimed to lower
HCY contained other treatments such as statins, fiber, or antioxidantrich juices. Reduction in HCY after 12-weeks with n-3 supplementation
(3.6 g/day) for otherwise healthy individuals with elevated HCY also
included statins, multivitamins and fiber; however, there was no
reduction in HCY in the placebo group (statins, only) [18]. Tomato
juice enriched with n-3 (250 mg EPA+DHA) significantly reduced
HCY (approximately 3 μM), after 2-weeks, as compared to tomato
juice without n-3 for a small sample of healthy women; however, by the
authors’ own admission, both juices provided antioxidant compounds
such as phenolics and lycopene [34].
Similarly, cross-sectional studies have shown high n-3 intake
associated with low HCY for patients with type 2 diabetes [28], healthy
males [36] and older Chinese adults [37]. The protective effect of n-3
may be attributed, in part, to its role in activating other antioxidants.
In fact, n-3 has been associated with increased activity of glutathione
peroxidase, an antioxidant enzyme with selenium acting as a cofactor,
in a population with type 2 diabetes [38].

Confounders of n-3 with CRP and HCY: metabolic state,
ethnicity, genetics
It has not been determined whether ethnic differences in the
relationships between either CRP or HCY can be attributed to
metabolic, cultural, or genetic factors. With respect to metabolic
differences, there is an increasing number of individuals, particularly
non-Caucasian ancestry, that are of a presumable ‘normal body weight’,
but have a phenotype that can be referred to ‘metabolically obese’ [39].
Increased susceptibility to CVD and diabetes may be due, in part,
to high free-radical level in plasma which impairs insulin function
[40]. The association of omega 3 intake with HCY and CRP for AA
in the present study may be due, in part, to their susceptibility to
cardiovascular disease; however, prospective studies are needed to
make any determinations. Another possible confounder is type of n-3
(EPA/DHA versus ALA) and its interaction with metabolic factors.
Metabolic effect differences were found between fish (a source of EPA/
J Nutr Food Sci
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DHA) and flaxseed oil (a source of ALA) on glucose homeostasis,
but not on CRP or lipid metabolism in a primarily Caucasian cohort
of women with polycystic ovary syndrome [41]. Although there were
several ethnicities in this 6-week prospective randomized controlled
study, their numbers were insufficient to access ethnic influence on
the effect of n-3 on metabolic outcomes [41]. For Caucasian patients
with end-stage renal disease, serum DHA, but not EPA was inversely
associated with plasma HCY [42]. The higher degree of unsaturation in
DHA (22:6) as compared to EPA (22:5) may be a factor in hemodynamic
and anti-atherogenic properties that affect HCY metabolism as well as
the metabolic state of the target population [43]. A major cultural factor
of ethnic differences, food preparation, may change the effectiveness of
n-3; in particular, deep frying [44]. Ethnic difference in cooking may
have influenced the relationship between n-3 with HCY and CRP. Food
preparation may differ by ethnicity for our participants since AA were
born in the US; whereas HA were all born in Haiti. Vast differences in
diet were reported between AA and HA [45]. Finally, genetic differences
among ethnicities may be a factor influencing the association of n-3
with HCY and CRP; however, there are no studies, to date, that have
investigated this area. Since n-3 has been shown to regulate gene
expression for antioxidant as well as reactive oxidative species, it is
plausible that the genetic differences between AA and HA may explain
differences in the effectiveness of n-3 in metabolic functions. The extent
to which the multifaceted aspects of ethnicity: metabolic, cultural, and
genetic, modify the relationship between n-3 with HCY and CRP has
not been established.

Limitations
This study had several limitations. The results were cross-sectional
and causality cannot be assumed. N-3 was assessed by a food frequency
questionnaire and the actual blood levels may differ. Food preparation
and self-report of dietary data may have bias the results. On the other
hand, a food frequency questionnaire could represent a yearly average
intake of n-3; whereas, blood levels of n-3 represent recent consumption.
Although other antioxidants were not correlated with CRP and HCY,
they were not considered in the final models and may have some
confounding effect in the relationship between n-3 consumption and
CRP and HCY levels.

Conclusion
N-3 intake was significantly associated with CRP and HCY levels
for AA but not for HA. Diabetes status and consumption of n-3
did not significantly predict odds of high CRP or high HCY. These
findings suggest the need for prospective and intervention studies of
measurement of n-3 in blood levels and cardiovascular events followup between and across multiethnic populations with and without type
2 diabetes.
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